$NVAX $BNTX Company Clinical Trial Phase Interim Data Reported Operation Warp Speed Funding Moderna Phase 3 as of July 27 Phase 1 $483 million Inovio Entering phase 2/3 this summer Phase 1 None AstraZeneca Phase 2/3 Phase 1/2 $1.2 billion Pfizer/BioNTech Entering phase 2b/3 in late July Phase 1/2 None CanSino Soon entering phase 3 Phase 2 None Sinovac Entering phase 3 in July Phase 2 None Novavax Phase 1/2 Phase 1 data expected early August $1.6 billion